The Times

.

GangaGen Secures additional US$7.9 Million from CARB-X for Pre-clinical Development of Novel Klebicins Targeting Nosocomial Pneumonia caused by Multidrug-resistant Klebsiella pneumoniae

BANGALORE, INDIA / SINGAPORE - Media OutReach Newswire - 23 December 2024 - GangaGen announced today that it has secured the third instalment of its phased funding grant from CARB-X (Combating Antibiotic-Resistant Bacteria Biopharmaceutical Accelerator), the global initiative led by Boston University to support the development of antibacterial products aimed at diagnosing, preventing, and treating drug-resistant infections.


Notice: Undefined offset: 1 in /httpdocs/templates/gk_university/html/pagination.php on line 18

Notice: Undefined offset: 1 in /httpdocs/templates/gk_university/html/pagination.php on line 34

Notice: Undefined offset: 2 in /httpdocs/templates/gk_university/html/pagination.php on line 34

Notice: Undefined offset: 3 in /httpdocs/templates/gk_university/html/pagination.php on line 34
hacklink hack forum hacklink film izle hacklink makrobetperabetgamdomkumar siteleriroyalbet girişcasibomNon GAMSTOP Casinoonline casinos australiaonline casinosonline casino australiaCasinos Not on GAMSTOP UKz-library genesisPadişahbet 2026Deneme bonusu veren siteler 2026Galabetjojobet girişjojobet girişjojobetjojobetcasibom girişcasibom girişultrabetjojobetjojobetcasibomip stresserjojobetjojobet